289 related articles for article (PubMed ID: 27601506)
21. The impact of genomics on the future of medicine and health.
Mattick JS; Dziadek MA; Terrill BN; Kaplan W; Spigelman AD; Bowling FG; Dinger ME
Med J Aust; 2014 Jul; 201(1):17-20. PubMed ID: 24999876
[No Abstract] [Full Text] [Related]
22. Individualized Therapy Is a Long-Term Cost-Effective Method Compared to Dose Intensification in Crohn's Disease Patients Failing Infliximab.
Steenholdt C; Brynskov J; Thomsen OØ; Munck LK; Fallingborg J; Christensen LA; Pedersen G; Kjeldsen J; Jacobsen BA; Oxholm AS; Kjellberg J; Bendtzen K; Ainsworth MA
Dig Dis Sci; 2015 Sep; 60(9):2762-70. PubMed ID: 25673037
[TBL] [Abstract][Full Text] [Related]
23. The Genomic Era of Clinical Oncology: Integrated Genomic Analysis for Precision Cancer Care.
Surrey LF; Luo M; Chang F; Li MM
Cytogenet Genome Res; 2016; 150(3-4):162-175. PubMed ID: 28002823
[TBL] [Abstract][Full Text] [Related]
24. Cancer Therapy Directed by Comprehensive Genomic Profiling: A Single Center Study.
Wheler JJ; Janku F; Naing A; Li Y; Stephen B; Zinner R; Subbiah V; Fu S; Karp D; Falchook GS; Tsimberidou AM; Piha-Paul S; Anderson R; Ke D; Miller V; Yelensky R; Lee JJ; Hong DS; Kurzrock R
Cancer Res; 2016 Jul; 76(13):3690-701. PubMed ID: 27197177
[TBL] [Abstract][Full Text] [Related]
25. Personalized medicine for patients with advanced cancer in the phase I program at MD Anderson: validation and landmark analyses.
Tsimberidou AM; Wen S; Hong DS; Wheler JJ; Falchook GS; Fu S; Piha-Paul S; Naing A; Janku F; Aldape K; Ye Y; Kurzrock R; Berry D
Clin Cancer Res; 2014 Sep; 20(18):4827-36. PubMed ID: 24987059
[TBL] [Abstract][Full Text] [Related]
26. Precision medicine: what's all the fuss about?
Barker R
Scand J Clin Lab Invest Suppl; 2016; 245():S2-5. PubMed ID: 27542001
[TBL] [Abstract][Full Text] [Related]
27. IMPRESS-Norway: improving public cancer care by implementing precision medicine in Norway; inclusion rates and preliminary results.
Puco K; Fagereng GL; Brabrand S; Niehusmann P; Støre Blix E; Samdal Steinskog ES; Haug Å; Fredvik Torkildsen C; Oppedal IA; Meltzer S; Flobak Å; Johansson KAM; Bjørge L; Hjortland GO; Dalhaug A; Lund JÅ; Gilje B; Grønlie Cameron M; Hovland R; Falk RS; Smeland S; Giercksky Russnes HE; Taskén K; Helland Å; ;
Acta Oncol; 2024 May; 63():379-384. PubMed ID: 38779911
[TBL] [Abstract][Full Text] [Related]
28. The Impact of Hospice Care on Survival and Healthcare Costs for Patients with Lung Cancer: A National Longitudinal Population-Based Study in Taiwan.
Chiang JK; Kao YH; Lai NS
PLoS One; 2015; 10(9):e0138773. PubMed ID: 26406871
[TBL] [Abstract][Full Text] [Related]
29. Experience with precision genomics and tumor board, indicates frequent target identification, but barriers to delivery.
Bryce AH; Egan JB; Borad MJ; Stewart AK; Nowakowski GS; Chanan-Khan A; Patnaik MM; Ansell SM; Banck MS; Robinson SI; Mansfield AS; Klee EW; Oliver GR; McCormick JB; Huneke NE; Tagtow CM; Jenkins RB; Rumilla KM; Kerr SE; Kocher JA; Beck SA; Fernandez-Zapico ME; Farrugia G; Lazaridis KN; McWilliams RR
Oncotarget; 2017 Apr; 8(16):27145-27154. PubMed ID: 28423702
[TBL] [Abstract][Full Text] [Related]
30. Cost-effectiveness of gene-expression profiling for tumor-site origin.
Hornberger J; Degtiar I; Gutierrez H; Shewade A; Henner WD; Becker S; Varadhachary G; Raab S
Value Health; 2013; 16(1):46-56. PubMed ID: 23337215
[TBL] [Abstract][Full Text] [Related]
31. Palliative care treatment patterns and associated costs of healthcare resource use for specific advanced cancer patients in the UK.
Guest JF; Ruiz FJ; Greener MJ; Trotman IF
Eur J Cancer Care (Engl); 2006 Mar; 15(1):65-73. PubMed ID: 16441679
[TBL] [Abstract][Full Text] [Related]
32. The Use of Targeted Therapies for Precision Medicine in Oncology.
White Al-Habeeb N; Kulasingam V; Diamandis EP; Yousef GM; Tsongalis GJ; Vermeulen L; Zhu Z; Kamel-Reid S
Clin Chem; 2016 Dec; 62(12):1556-1564. PubMed ID: 27679436
[No Abstract] [Full Text] [Related]
33. Precision medicine for patients with advanced biliary tract cancers: An effective strategy within the prospective MOSCATO-01 trial.
Verlingue L; Malka D; Allorant A; Massard C; Ferté C; Lacroix L; Rouleau E; Auger N; Ngo M; Nicotra C; De Baere T; Tselikas L; Ba B; Michiels S; Scoazec JY; Boige V; Ducreux M; Soria JC; Hollebecque A
Eur J Cancer; 2017 Dec; 87():122-130. PubMed ID: 29145038
[TBL] [Abstract][Full Text] [Related]
34. The NEXT-1 (Next generation pErsonalized tX with mulTi-omics and preclinical model) trial: prospective molecular screening trial of metastatic solid cancer patients, a feasibility analysis.
Kim ST; Lee J; Hong M; Park K; Park JO; Ahn T; Park SH; Park YS; Lim HY; Sun JM; Ahn JS; Ahn MJ; Kim HC; Sohn TS; Choi DI; Cho JH; Heo JS; Kwon W; Uhm SW; Lee H; Min BH; Hong SN; Kim DH; Jung SH; Park W; Kim KM; Kang WK; Park K
Oncotarget; 2015 Oct; 6(32):33358-68. PubMed ID: 26396172
[TBL] [Abstract][Full Text] [Related]
35. Comparative cost-effectiveness of bevacizumab-irinotecan-fluorouracil versus irinotecan-fluorouracil in first-line metastatic colorectal cancer.
Ruiz-Millo O; Albert-Mari A; Sendra-Garcia A; Jimenez-Torres NV
J Oncol Pharm Pract; 2014 Oct; 20(5):341-50. PubMed ID: 24177355
[TBL] [Abstract][Full Text] [Related]
36. Critical Care and Personalized or Precision Medicine: Who needs whom?
Sugeir S; Naylor S
J Crit Care; 2018 Feb; 43():401-405. PubMed ID: 29174462
[TBL] [Abstract][Full Text] [Related]
37. Health Care Resource Utilization and Associated Costs Among Metastatic Cutaneous Melanoma Patients Treated with Ipilimumab (INTUITION Study).
McArthur GA; Mohr P; Ascierto PA; Arance A; Banos Hernaez A; Kaskel P; Weichenthal M; Shinde R; Stevinson K
Oncologist; 2017 Aug; 22(8):951-962. PubMed ID: 28526721
[TBL] [Abstract][Full Text] [Related]
38. Impact of donepezil use in routine clinical practice on health care costs in patients with Alzheimer's disease and related dementias enrolled in a large medicare managed care plan: a case-control study.
Lu S; Hill J; Fillit H
Am J Geriatr Pharmacother; 2005 Jun; 3(2):92-102. PubMed ID: 16129386
[TBL] [Abstract][Full Text] [Related]
39. Cost Implications of Value-Based Pricing for Companion Diagnostic Tests in Precision Medicine.
Zaric GS
Pharmacoeconomics; 2016 Jul; 34(7):635-44. PubMed ID: 26899833
[TBL] [Abstract][Full Text] [Related]
40. Evaluating the financial impact of clinical trials in oncology: results from a pilot study from the Association of American Cancer Institutes/Northwestern University clinical trials costs and charges project.
Bennett CL; Stinson TJ; Vogel V; Robertson L; Leedy D; O'Brien P; Hobbs J; Sutton T; Ruckdeschel JC; Chirikos TN; Weiner RS; Ramsey MM; Wicha MS
J Clin Oncol; 2000 Aug; 18(15):2805-10. PubMed ID: 10920127
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
